🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The 11th annual ARDD Meeting kicks off with leaders Alex Zhavoronkov (Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)), and Profs. Morten Scheibye-Knudsen (The Scheibye-Knudsen Lab) & Daniela Bakula. Over 160 aging experts gather today! #longevity #aging #drugdiscovery #biotech longevity.technology/news/ardd-2024…

Openwater aims to transform healthcare with a $100m open-source, drug-free tech. Leveraging semiconductor physics plus light & sound, it diagnoses and treats diseases at the cellular level. Mary Lou Jepsen, PhD Peter Gabriel #longevity #investment #healthcare bit.ly/4e1yE5R

As ARDD gets underway, Life Bio’s CEO explains how the conference is helping move age-targeting interventions closer to the clinic. Life Biosciences @ARDD_meeting #longevity #rejuvenation #healthspan #ARDD bit.ly/3z4PkdV

Researchers discover protein that prevents DNA damage DdrC protein repairs broken DNA fragments, restoring genomic coherence and making cells resistant to extreme conditions. Western University CanadianLightSource #longevity #research #DNA longevity.technology/news/researche…

Breaking news! Founders Longevity Forum heads to Singapore. Collaboration between Longevity Technology, Founders Forum Group and Yong Loo Lin School of Medicine combines clinical, biotech, investment & consumer longevity. Andrea Maier Carolyn Dawson #longevity #investment #Singapore bit.ly/3yMuakX

Navigator lands $100m to advance ‘targeted immune regulation and restoration’ pipeline Targeting inflammatory diseases, company gears up for trials of in-licensed OX40L and TNF alpha inhibitor. #longevity #investment #biotech #inflammation Forbion longevity.technology/news/navigator…

Investors & innovators set to gather at Longevity Investors Conference. Highly anticipated conference returns to Switzerland next month w/ extended agenda & expert keynotes. Maximon Dr. Tobias Reichmuth Marc P. Bernegger 👾 MP₿ #longevity #investment #startups #biotech bit.ly/4dFaWNj

Yuva Bio and Elevai combine mitochondrial and exosome tech for hair loss treatment Companies file joint patents relating to synergistic combination and collaborate on new hair and scalp care product. @yuvabio #longevity #hairloss #mitochondria longevity.technology/news/yuva-bio-…

ARDD 2024: from Big Pharma to big proposals. Aging #drugdiscovery meeting demonstrates longevity is attracting the attention of those outside the geroscience field. @ardd_meeting David Sinclair @andreabmaier Andrew Steele Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs) #longevity #aging bit.ly/4g3pk3n

Altos Labs launches AI and computational biology institute Cellular rejuvenation company aims to advance new computational models to ‘decode the language of cellular resilience.’ Altos Labs #longevity #AI #biotech #computing longevity.technology/news/altos-lab…

Thryve lands €4m to advance preventive health technology Platform integrates health data from hundreds of health apps and wearables to enable preventive care and automated treatment. Thryve #longevity #investment #healthdata #prevention longevity.technology/news/thryve-la…

Leading cardiologist suggests weight loss drugs like Ozempic may slow aging Study shows semaglutide has ‘far-reaching benefits’ and potential to protect against a ‘broad spectrum’ of health threats. #longevity #aging #Ozempic #semaglutide longevity.technology/news/leading-c…

A healthier – and wealthier – future needs a holistic approach Nadine Esposito on why focusing on finance and collaborating with healthcare is essential for the longevity space. #investment #economy #holistichealth #healthcare #longevity longevity.technology/news/a-healthi…

Lucid Genomics emerges with AI platform that unravels the secrets of the ‘dark genome’ Berlin startup focuses on ‘whole genome’ analysis to identify genetic variations with greater accuracy. MaxPlanck-Innovation #longevity #AI #genomics longevity.technology/news/lucid-gen…

Researchers target ‘drug free life’ for rheumatoid arthritis patients Australian-led research project lands $11.5 million grant to advance RA immunotherapy into clinical trials. #longevity #arthritis #immunotherapy longevity.technology/news/researche…

BioAge Labs files for IPO Longevity biotech to become sector’s next public company as it seeks to develop an all-oral combination treatment for obesity. #longevity #biotech #investment #IPO longevity.technology/news/bioage-la…

Vesper Bio touts positive FTD trial results for sortilin inhibitor Company readies for Phase 2 studies after frontotemporal dementia drug demonstrates key target engagement. #longevity #biotech #dementia longevity.technology/news/vesper-bi…

eGenesis lands $191m to advance xenotransplantation into clinical trials Company targets organ transplant shortage after world’s first successful transplant of genetically edited pig kidney into humans. #longevity #investment #kidney #transplant longevity.technology/news/egenesis-…

Charity launches at-home #bloodtest that predicts #dementiarisk Food for the Brain develops pin-prick test that measures #glutathione levels in blood to assess rate of brain aging. #diagnostics #selftesting #dementia #dementiaawareness #dementiasupport longevity.technology/news/charity-l…

‘Four FDA-approved drugs decrease overall mortality in humans’ Ahead of his appearance at Longevity Investors Conference, Nir Barzilai talks gerotherapeutics and choosing the right drugs for aging. #biotech #economy #Gstaad #gerotherapeutics #longevity longevity.technology/news/four-fda-…